Research and Development

The administration of New York City Mayor Bill de Blasio has announced its intention to bring legal action against the …

Eli Lilly has revealed that its IgG4 monoclonal antibody Taltz (ixekizumab) has been awarded marketing approval from the European Commission …

NICE has said that a new online and mobile app should be trialled on the NHS in the treatment of …

In yet more bad news for Teva, it has emerged that two of the firm’s late-stage studies in asthma have …

Michael Adeogun, Head of Life Sciences and Health at National Physical Laboratory, discusses the importance of effective measurement for the …

It’s Friday, so it’s time to bring you another run-down of the top ten most popular articles with Pharmafile.com’s readers …

Although those in pharma often dislike any references to drugs competing with each other for market as in a ‘race’, …

AstraZeneca and X-Chem are to expand their existing drug discovery collaboration, it has emerged. The partnership marks the third agreement …

Following on from this week’s earlier piece on real world evidence, Jacqueline Corrigan-Curay, Director of CDER’s Office of Medical Policy at the FDA, …

Evidence is mounting against the efficacy of the common morning sickness pill pyridoxine-doxylamine  (Diclegis, Diclectin), as new study data reveals …

For women, possessing a mutated BRCA1 or BRCA2 gene significantly increases the chances of developing breast or ovarian cancer; at …

Ipsen and Exelixis, partners in developing Cabometyx (cabozantinib), have revealed that they have cut short a Phase 3 trial into …

Following up last year’s ground-breaking news that CAR T therapy Kymriah had become the first such treatment to be approved …

Engineers at the University of Connecticut have developed a biodegradable pressure sensor which is designed to, once ingested, aid in …

Celgene has already started off the year with a bang, announcing a deal with Impact Biomedicines worth a potential $7 …